24 yılda 132 bilim kadınına destek
L’Oréal Türkiye, UNESCO iş birliğiyle yürüttüğü ‘Bilim Kadınları İçin’ programının 24’üncü yılında dört bilim kadınını daha destekleyerek Türkiye’de ulaştığı kadın araştırmacı sayısını 132’ye çıkardı.
Kadın sağlığından yenilenebilir enerjiye kadar geniş bir alanda bilimsel çalışmaları destekleyen program, toplumsal cinsiyet eşitliğini odağına almayı sürdürüyor.
Başak Nur GÖKÇAM (@yesil_yakali) haberi...
https://t.co/hGbtpZmjyP
Discovery of a Novel 4,5-Dihydro-1H-pyrazole-1-carbothioamide Derivative with Cytotoxic, Apoptotic, and ABL1 Inhibitory Activities Against Chronic Myeloid Leukemia https://t.co/nYDUVQhDAG #mdpibiomedicines via @Biomed_MDPI
Structural and Computationally Driven Molecule Design in Drug Discovery: Current Advances and Future Perspectives https://t.co/UKRc6aCBGF #mdpipharmaceuticals via @Pharmaceut_MDPI
Design, Synthesis and Biological Evaluation of Novel Oleanolic Acid Derivatives as Potential Anti-Leukemic Agents https://t.co/RGN8L9y5ZL #mdpilife via @Life_MDPI
Pharmaceuticals Webinar | Structural and Computationally Driven Molecule Design in Drug Discovery https://t.co/F1Fv5kCY4u #Pharmaceuticals7 via @sciforum
Bir fikrin hikâyesi 2. bölümüyle yayında!
Konuğumuz,
“HIV Tedavisi İçin Matriks Antijen (MA) Hedefli Yeni İlaç Adaylarının Geliştirilmesi” ve “Development of Edaravone–c-Abl Inhibitor Hybrids as Next-Generation ALS Therapeutics” projeleriyle Doç. Dr. Belgin Sever.
Bilimsel üretimin uluslararası iş birlikleriyle nasıl büyüdüğünü bu bölümde konu��uyoruz.
Programı izlemek için ▶️ https://t.co/f2xwcHLTMN
Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential Anticancer Activity https://t.co/G499F9s1M9 #mdpipharmaceuticals via @Pharmaceut_MDPI
Targeting leukemic stem cells: enhanced eradication via tivantinib (ARQ197) and asciminib (ABL001) with molecular docking-guided screening of therapeutic derivatives: Journal of Chemotherapy: Vol 0, No 0 - Get Access https://t.co/8kMIY9zAt1
Design, Synthesis, and Anticancer Evaluation of New Small-Molecule EGFR Inhibitors Targeting NSCLC and Breast Cancer https://t.co/B1xITBxaCf #mdpiijms via @IJMS_MDPI
A Structural Insight Into Two Important ErbB Receptors (EGFR and HER2) and Their Relevance to Non‐Small Cell Lung Cancer - Topalan - 2025 - Archiv der Pharmazie - Wiley Online Library https://t.co/1dxSf6L99k
Design, Synthesis, and Mechanistic Anticancer Evaluation of New Pyrimidine-Tethered Compounds https://t.co/pYeIkP78GM #mdpipharmaceuticals via @Pharmaceut_MDPI
Plant Product- and/or Synthetic Compound-Based Drug Development for Livestock Disease Treatment https://t.co/p5LqtIDDbi #mdpimolecules via @Molecules_MDPI